Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females

NCT02792517 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Headache, Migraine

Interventions

DRUG: Erenumab
DRUG: Ethynil Estradiol/Norgestimate Oral Contraceptive

Sponsor

Amgen